Grandix Global Pharma Private Limited
Founded in 2017 and headquartered in Tamil Nadu, India.
2017 | Tiruvallur, Tamil Nadu (India) | Active
Grandix Global Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 1.91 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -41.14%
- Profit Growth 121.57%
- Ebitda 99.91%
- Net Worth 2.98%
- Total Assets 4.11%
About Grandix Global Pharma
Grandix Global Pharma Private Limited (GGPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 May 2017 (Seven years and 11 months 22 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Corporate was formerly known as Avaance Lifesciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.91 M, as per Ministry of Corporate Affairs (MCA) records.
Karnnanidhi Ramanar, Venkataraghavan Sourirajan, and Latha Subramanian serve as directors at the Company.
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909TN2017PTC116820
- Company No.
116820
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Pharma
Grandix Global Pharma Private Limited
Explore comprehensive data for Grandix Global Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Grandix Global Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkataraghavan Sourirajan  | Director | 29-May-2017 | Current |
| Karnnanidhi Ramanar | Director | 29-May-2017 | Current |
| Latha Subramanian | Additional Director | 01-Apr-2024 | Current |
Financial Performance of Grandix Global Pharma.
Grandix Global Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 41.14% decrease. The company also saw a substantial improvement in profitability, with a 121.57% increase in profit. The company's net worth moved up by a moderate rise of 2.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Grandix Global Pharma?
Unlock access to Grandix Global Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Olympus Therapeutics Private LimitedKarnnanidhi Ramanar and Latha Subramanian are mutual person
Grandix Speciality Formulations Private LimitedLatha Subramanian is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Grandix Global Pharma?
Unlock and access historical data on people associated with Grandix Global Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Grandix Global Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grandix Global Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Grandix Global Pharma
Recent activity within the organization
- Director Appointment
Latha Subramanian was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2024 & has been associated with this company since 1 year 1 month .
- Annual General Meeting
Grandix Global Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Grandix Global Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chennai.
- Director Appointment
Karnnanidhi Venneela Ramanar was appointed as a Director was appointed as a Director on 29 May 2017 & has been associated with this company since 7 years 11 months .
- Director Appointment
Venkataraghavan Sourirajan was appointed as a Director was appointed as a Director on 29 May 2017 & has been associated with this company since 7 years 11 months .
- Company Incorporation
Grandix Global Pharma Private Limited was registered on 29 May 2017 with Roc Chennai & aged 7 years 11 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Grandix Global Pharma Private Limited?
Grandix Global Pharma Private Limited was incorporated on 29 May 2017.
What is authorized share capital and paid-up capital of Grandix Global Pharma Private Limited?
The authorized share capital of Grandix Global Pharma Private Limited is ₹ 3.00 M and paid-up capital is ₹ 1.91 M.
Who are the current board members & directors of Grandix Global Pharma Private Limited?
Currently 3 directors are associated with Grandix Global Pharma Private Limited.
- Karnnanidhi Venneela Ramanar
- Venkataraghavan Sourirajan
- Latha Subramanian
What is the registered address of Grandix Global Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Grandix Global Pharma Private Limited is No. 253 2Nd Street Velan Nagar Valasaravakkam, India, Chennai, Tamil Nadu, 600087.
What is the corporate identification number (CIN) and company number of Grandix Global Pharma Private Limited?
The corporate identification number (CIN) of Grandix Global Pharma Private Limited is U51909TN2017PTC116820 and the company number is 116820 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Grandix Global Pharma Private Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Grandix Global Pharma Private Limited has fallen by -41.14%.
What change has been observed in the net worth of Grandix Global Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Grandix Global Pharma Private Limited has experienced an upsurge of 2.98%.
When was the last Balance Sheet of Grandix Global Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Grandix Global Pharma Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records